Infinity Pharmaceuticals | INFI - Stock


Infinity Pharmaceuticals reported $0 in Stock for its fiscal quarter ending in September of 2021.





Stock Change Date
AbbVie USD 4.95B 13M Dec/2025
Amgen USD 6.22B 121M Dec/2025
AstraZeneca USD 6.59B 126M Sep/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Cipla INR 61.6B 5.18B Sep/2025
Clal Biotechnology ILS 4.44M 0 Mar/2021
CSL USD 6.47B 327M Jun/2025
Eisai JPY 236.46B 9.14B Sep/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Gilead Sciences USD 1.78B 40M Sep/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
Grifols EUR 3.56B 63.19M Dec/2024
Incyte USD 101.06M 17.61M Dec/2025
Infinity Pharmaceuticals USD 0 0 Sep/2021
Ionis Pharmaceuticals USD 10.47M 1.99M Sep/2025
J&J USD 14.19B 45M Dec/2025
Novartis USD 6.42B 114M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
Plus Therapeutics USD 0 0 Jun/2022
Roche Holding CHF 7.6B 9M Jun/2025
TG Therapeutics USD 146.95M 8.25M Sep/2025